Automated Analyzers Market Forecasts to 2028 – Global Analysis By Analyzer (Hematology Analyzers, Biochemistry Analyzers, Immuno-based Analyzers and Other Analyzers), Wing Type (Fixed Wing Aircraft and Rotary Wing Aircraft), Application, End User and By Geography
According to Stratistics MRC, the Global Automated Analyzers Market is accounted for $7.5 billion in 2022 and is expected to reach $12.7 billion by 2028 growing at a CAGR of 9.1% during the forecast period. A medical laboratory device called an automated analyzer may be created to quickly and effectively measure various chemical compositions and other parameters in a large number of gathered biological samples with little help from humans. Tools also allow for the examination of a wide variety of samples and the quick generation of data, indicating future uses for them in hospitals, outpatient clinics, and surgical as well as emergency wards.
According to the WHO, infectious diseases are the world's leading cause of death, accounting for more than 13 million deaths per year, with one in every two deaths occurring in underdeveloped nations.
Market Dynamics
Driver:
Growing prevalence of infectious diseases
The resources used by healthcare services are put under tremendous strain by the rising prevalence of infectious diseases. The increased number of Eosinophil Sedimentation Rate (ESR) tests is likely due in part to the increasing number of infectious infections that are continuously causing various health risks. Also, the requirements from the respective governments and the rising need for integrated healthcare systems are significant drivers of the market's expansion.
Restraint
Technical issues related to automated analyzers
Automatic analyzers are frequently intricate systems that call for unique expertise to maintain and operate. Smaller or less technologically advanced healthcare providers could find this challenging since they do not have the staff or resources they need to use these systems efficiently. Inaccuracies in test results and improper diagnosis or treatment may come from improper calibration and upkeep of these systems. Thus, this factor may impede demand for the market.
Opportunity
Increasing adoption of laboratory automation
Using cutting-edge technology like machine learning, robots, and artificial intelligence, laboratory automation entails automating operations in the lab, such as sample preparation, analysis, and data management. Laboratory automation is quickly being adopted because it provides numerous benefits such as enhanced efficiency, precision, and reproducibility, as well as lowers labour costs and turnaround time, which are driving market growth.
Threat
The shortage of skilled professionals
Businesses need to make significant investments in training their staff members on how to use these tools efficiently. This may limit their adoption in environments where staff could lack the necessary skills, which in turn may limit their acceptance to some extent. Yet the high cost of automated analyzer products, the labour shortage, and the increasing sophistication of automated analyzers will prove to be obstacles to the market's expansion.
Covid-19 Impact
The COVID-19 pandemic lockdown measures put in place by many governments have raised demand for automated analyzers, notably for diagnostic testing. Automatic analyzers may swiftly and accurately carry out a variety of diagnostic procedures, such as nucleic acid amplification tests for finding SARS-CoV-2, the virus that causes the disease. Throughout the epidemic, demand has increased dramatically, and automated analyzers have been crucial in boosting testing capacity and speeding up turnaround times.
The immuno-based analyzer segment is expected to be the largest during the forecast period
The immuno-based analyzer segment is estimated to have a lucrative growth, due to growing demand in clinical chemistry and immunoassay. Medical devices called immuno-based analyzers automatically conduct tests on patient samples to find any biologically active components. These analyzers are mostly employed in the diagnosis of cancer, cardiac, autoimmune, and infectious illnesses. The market is anticipated to expand in this sector due to the development of immunochemistry analyzers.
The genomics segment is expected to have the highest CAGR during the forecast period
The Genomics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the uses of automated analyzers in genomics. This indicates that the majority of operations can be completed in a sequential manner with more accuracy than manual analysis. Getting a lot of data in a timely manner at a fair cost is one of the main objectives for many studies. The creation of libraries, sequencing, and duplication marking are all tasks performed by automated analyzers in genomics.
Region with Largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to rise in the consciousness among the people about cardiac analysis, allergy testing, blood cell counts and others. In addition, rising healthcare awareness, an increase in the number of pharmaceutical firms in the area, and an increase in the number of patients with blood disorders are all expected to help the industry develop.
Region with highest CAGR
North America is projected to have the highest CAGR over the forecast period, owing to the existence of improved healthcare infrastructure and major manufacturers increasing the investments in R&D activities. Also, the region's market is expected to develop as a result of the government's increased efforts to automate diagnosis analyzers and the large number of chemical and pharmaceutical industries who have adopted automated analyzers for R&D operations.
Key players in the market
Some of the key players profiled in the Automated Analyzers Market include Hudson Robotics Inc., Thermo Fisher Scientific, Honeywell International Inc., Tecan Group Ltd., Becton Dickinson, Siemens Healthineers AG, Danaher Corporation, PerkinElmer Inc., Synchron Lab Automation, Agilent Technologies Inc., HORIBA, Ltd., ELITechGroup, Ortho Clinical Diagnostics, Aurora Biomed, Eppendorf AG and Yokogawa Electric Co., Ltd.
Key Developments
In February 2021, Yokogawa Electric Co., Ltd. and HIROT SUBIO SCIENCE (HBS) have signed an investment partnership agreement with the aim of expanding the use of HBS’s N-NOSE cancer screening service, which detects cancer using the highly sensitive olfactory function of nematodes.
In September 2019, Thermo Fisher Scientific designed a new workflow to provide a validated analytical method combining advanced high-performance liquid chromatography (HPLC) and triple quadrupole mass spectrometry (MS) capabilities for the reliable and sensitive quantitation of pesticides in complex sample matrices.
Analyzers Covered:
• Hematology Analyzers
• Biochemistry Analyzers
• Immuno-based Analyzers
• Other Analyzers
Applications Covered:
• Bioanalysis
• Analytical Chemistry
• Genomics
• Clinical Diagnostics
• Drug Discovery
• Proteomics
• Other Applications
End Users Covered:
• Oil & Gas
• Chemical
• Healthcare
• Other End Users
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook